S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2025

RTW Investments

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$7.02B
Total portfolio value
Positions
73
Reported securities
Top Holding
MDGL
8.6% $603.4M
QoQ Changes
+8 / -6
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$603.4M8.59%$302.64$528.10+74.5%
8.6%
NTRANATERA INC$438.2M6.24%$168.94$279.32+65.3%
6.2%
PTCTPTC THERAPEUTICS INC$378.3M5.39%$48.84$83.31+70.6%
5.4%
ARGXARGENX SE$371.3M5.29%$551.22$939.68+70.5%
5.3%
PTGXPROTAGONIST THERAPEUTICS INC$318.1M4.53%$55.27$131.62+138.1%
4.5%
INSMINSMED INC$310.4M4.42%$100.64$111.60+10.9%
4.4%
AKROAKERO THERAPEUTICS INC$292.3M4.16%β€”β€”
4.2%
VRNAVERONA PHARMA PLC$288.6M4.11%β€”β€”
4.1%
RNAMAVIDITY BIOSCIENCES INC$273.2M3.89%β€”β€”
3.9%
SYKSTRYKER CORPORATION$233.6M3.33%$391.64$326.54-16.6%
3.3%
PENPENUMBRA INC$221.6M3.16%$256.63$318.57+24.1%
3.2%
MRUSMERUS N V$210.4M3.00%β€”β€”
3.0%
ACADACADIA PHARMACEUTICALS INC$194.0M2.76%$21.57$25.97+20.4%
2.8%
ZLABZAI LAB LTD$193.6M2.76%$34.97$19.12-45.3%
2.8%
AXSMAXSOME THERAPEUTICS INC$158.3M2.26%$104.39$244.31+134.0%
2.3%
RDNTRADNET INC$153.1M2.18%$56.91$68.75+20.8%
2.2%
IMCRIMMUNOCORE HLDGS PLC$152.8M2.18%$31.38$32.50+3.6%
2.2%
ALKSALKERMES PLC$134.0M1.91%$28.61$54.58+90.8%
1.9%
NBIXNEUROCRINE BIOSCIENCES INC$133.5M1.90%$125.69$174.26+38.6%
1.9%
TARSTARSUS PHARMACEUTICALS INC$126.0M1.80%$40.51$65.44+61.5%
1.8%
APGEAPOGEE THERAPEUTICS INC$117.8M1.68%$43.43$132.91+206.0%
1.7%
MASIMASIMO CORP$114.9M1.64%$168.22β€”
1.6%
ESTAESTABLISHMENT LABS HLDGS INC$110.4M1.57%$42.71$89.25+109.0%
1.6%
ISRGINTUITIVE SURGICAL INC$110.0M1.57%$543.41$426.01-21.6%
1.6%
CYTKCYTOKINETICS INC$89.9M1.28%$33.04$86.49+161.8%
1.3%
DGXQUEST DIAGNOSTICS INC$89.8M1.28%$176.45$215.72+22.3%
1.3%
QUREUNIQURE NV$71.9M1.02%$13.94$41.81+199.9%
1.0%
GHRSGH RESEARCH PLC$67.5M0.96%$12.19$27.01+121.6%
1.0%
URGNUROGEN PHARMA LTD$62.3M0.89%$13.70$38.02+177.5%
0.9%
RAREULTRAGENYX PHARMACEUTICAL IN$62.1M0.88%$36.36$33.47-8.0%
0.9%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (8)

TickerIssuerNotionalSince Filing
NBIXNEUROCRINE BIOSCIENCES INC$133.5M+38.6%
ABTABBOTT LABS$60.4M
GHGUARDANT HEALTH INC$44.6M
SLNOSOLENO THERAPEUTICS INC$35.6M
MLTXMOONLAKE IMMUNOTHERAPEUTICS$35.0M
JBIOJADE BIOSCIENCES INC$14.5M
CRNXCRINETICS PHARMACEUTICALS IN$13.4M
RAPTRAPT THERAPEUTICS INC$11.8M

Exited Positions (6)

TickerIssuerNotional
GMEDGLOBUS MED INC$82.3M
ARVNARVINAS INC$23.4M
GKOSGLAUKOS CORP$18.7M
RAPTRAPT THERAPEUTICS INC$14.3M
BEAMBEAM THERAPEUTICS INC$8.6M
BIOABIOAGE LABS INC$3.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CNTACENTESSA PHARMACEUTICALS PLC$19.4M+2959.7%
DGXQUEST DIAGNOSTICS INC$73.1M+405.1%+22.3%
ALURALLURION TECHNOLOGIES INC$2.8M+142.1%
ZLABZAI LAB LTD$80.3M+76.5%-45.3%
CMPSCOMPASS PATHWAYS PLC$7.2M+48.5%
TSHATAYSHA GENE THERAPIES INC$31.7M+33.2%
QUREUNIQURE NV$26.7M+20.9%+199.9%
GEHCGE HEALTHCARE TECHNOLOGIES I$4.4M+20.4%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
CRGXCARGO THERAPEUTICS INC$-11.8M-70.6%
AXSMAXSOME THERAPEUTICS INC$-182.5M-48.1%+134.0%
ALKSALKERMES PLC$-93.4M-32.0%+90.8%
AKROAKERO THERAPEUTICS INC$-8.1M-26.2%
TARSTARSUS PHARMACEUTICALS INC$-44.3M-6.2%+61.5%
MRUSMERUS N V$34.9M-4.0%
BBNXBETA BIONICS INC$7.7M+0.0%
← Back to Hedge Funds